| Literature DB >> 31849318 |
Sarah H Kehoe1, Ghattu V Krishnaveni2, Sargoor Veena2, Krishnarajasagara N Kiran2, Samuel C Karat2, Asha Dhubey2, Patsy Coakley3, Caroline H D Fall3.
Abstract
BACKGROUND: The aim of this study was to determine whether physical activity volume and intensity in mid-childhood and early adolescence were associated with cardiometabolic risk factors at 13.5 years.Entities:
Keywords: Adolescent; Cardiometabolic risk; Children; India; Insulin resistance; Physical activity
Mesh:
Year: 2019 PMID: 31849318 PMCID: PMC6918651 DOI: 10.1186/s12887-019-1855-2
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Fig. 1Participant flow chart
Physical activity measures at 6–10 years and 11–13 years*
| 6–10 years | 11–13 years | |||||
|---|---|---|---|---|---|---|
| Physical Activity measures* | Males | Females | Males | Females | ||
| Counts/ day (× 103) | 448 ± 128 | 381 ± 110 | < 0.01 | 418 ± 144 | 296 ± 101 | < 0.01 |
| Registered Time (min/d) | 798 ± 81 | 783 ± 77 | 0.11 | 778 ± 86 | 760 ± 74 | 0.03 |
| Sedentary (% of RT) † | 40.7 ± 9.6 | 42.6 ± 9.5 | 0.51 | 47.9 ± 11.1 | 53.6 ± 10.0 | < 0.01 |
| Light physical activity (% of RT)† | 53.0 ± 8.3 | 52.8 ± 8.7 | 0.38 | 46.2 ± 9.6 | 43.2 ± 9.2 | < 0.01 |
| Moderate physical activity (% of RT)† | 5.0 ± 2.2 | 3.6 ± 1.7 | < 0.01 | 4.7 ± 2.5 | 2.8 ± 1.6 | < 0.01 |
| Vigorous physical activity (% RT)† | 1.1 (0.5, 2.0) | 0.8 (0.4,1.3) | < 0.01 | 0.8 (0.4,1.7) | 0.3 (0.1,0.6) | < 0.01 |
*Data are expressed as mean ± SD for normally distributed variables and as median (IQR) for non-normally distributed variables. †Intensity cut offs are those published by Evenson [30]; CPM Counts per minute, RT registered time p value refers to t test of difference between males and females
Tracking of physical activity between childhood and early adolescence; partial Pearson’s correlation adjusted for sex and age at 6–10 year measurement (n = 290)
| 11–13 year Physical activity measures | ||||||
|---|---|---|---|---|---|---|
| Counts/ day | % time Sedentary | % time Light | % time Moderate | % time Vigorous | ||
| 6–10 year Physical activity measures | Counts/day | 0.32** | −0.24** | 0.20* | 0.26** | 0.18* |
| % time Sedentary | −0.30** | 0.35** | −0.33** | −0.23** | − 0.06 | |
| % time Light | 0.26** | −0.34** | 0.34** | 0.18* | 0.01 | |
| % time Moderate | 0.24** | −0.19* | 0.14* | 0.26** | 0.14* | |
| % time Vigorous | 0.13* | −0.07 | 0.03 | 0.14* | 0.20* | |
*p for correlation <0.05, **p for correlation <0.001
Body composition and chronic disease risk factor measurements at 13.5 years*
| Males ( | Females ( | ||
|---|---|---|---|
| Measures at 13.5y | |||
| Weight (kg) | 40.8 ± 8.3 | 43.5 ± 8.4 | < 0.01 |
| Height (cm) | 154.4 ± 8.2 | 153.5 ± 5.9 | 0.22 |
| BMI (kg/m2) | 16.4 (15.4,18.0) | 17.9 (16.2, 20.3) | < 0.01 |
| Waist circumference (cm) | 65.5 ± 7.7 | 67.7 ± 7.9 | < 0.01 |
| Waist Hip Ratio | 0.89 ± 0.05 | 0.87 ± 0.05 | < 0.01 |
| MUAC (cm) | 21.9 ± 2.7 | 22.3 ± 2.7 | 0.07 |
| Triceps skin-fold (mm) | 9.6 (7.7, 14.1) | 14.5 (11.2, 18.4) | < 0.01 |
| Subscapular skin-fold (mm) | 9.2 (7.2, 13.6) | 15.3 (11.3, 20.3) | < 0.01 |
| Sum of skinfolds (mm) | 18.3 (15.0, 28.6) | 29.4 (22.3, 39.5) | < 0.01 |
| Fat % from bio-impedance | 17.6 ± 6.9 | 26.1 ± 5.8 | < 0.01 |
| Systolic blood pressure | 110.5 ± 8.9 | 107.9 ± 7.9 | < 0.01 |
| Diastolic blood pressure | 62.3 ± 7.9 | 58.8 ± 6.8 | < 0.01 |
| Fasting glucose (mmol/L) | 5.07 ± 0.53 | 5.02 ± 0.48 | 0.39 |
| Fasting insulin (pmol/L) | 33.7 (22.4, 48.8) | 46.1 (36.5, 64.4) | < 0.01 |
| HOMA-IR | 1.27 (0.82, 1.80) | 1.76 (1.35, 2.38) | < 0.01 |
| Total cholesterol (mmol/L) | 3.45 ± 0.69 | 3.59 ± 0.62 | 0.04 |
| HDL cholesterol (mmol/L) | 1.07 ± 0.25 | 1.06 ± 0.23 | 0.52 |
| LDL cholesterol (mmol/L) | 2.01 ± 0.55 | 2.13 ± 0.48 | 0.04 |
| Triglycerides (mmol/L) | 0.69 (0.49, 0.98) | 0.79 (0.60, 1.07) | 0.02 |
*Values are mean ± SD for normally distributed variables and median (inter-quartile range) for non-normally distributed variables. p value refers to t test of difference between males and females. MUAC Mid-upper arm circumference, HOMA Homeostasis Model Assessment for insulin resistance
Univariate linear regression models with physical activity measures as independent variables and 13.5 year cardiometabolic risk factors as the dependent variables (n = 290)
| 13.5y Risk Factors | ||||||||
|---|---|---|---|---|---|---|---|---|
| HOMA-IR | Fat % | Sum of Skinfolds (mm) | Waist Circumference (cm) | Total:HDL Cholesterol | Triglycerides | SBP (mmHg) | Metabolic Syndrome Score§ | |
| B (95% CI) | ||||||||
| 6–10 year Physical Activity | ||||||||
| Counts/day × 103 | 0.00 | −0.01* | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| (−0.01, 0.01) | (−0.02,−0.01) | (−0.01,0.01) | (−0.01,0.01) | (−0.01,0.01) | (−0.01,0.01) | (−0.01,0.01) | (−0.02,0.03) | |
| % time Moderate | −0.04 | −0.57* | 0.03 | 0.02 | 0.02 | 0.03 | −0.01 | 0.08 |
| (−0.10, 0.03) | (−1.00,−0.15) | (−0.03,0.09) | (−0.03,0.08) | (−0.04,0.07) | (−0.03,0.08) | (−0.06,0.05) | (−0.10,0.25) | |
| % time Vigorous | −0.07 | −0.97* | −0.02 | −0.01 | −0.10 | −0.08 | −0.04) | −0.20 |
| (−0.20, 0.06) | (−1.87,−0.08) | (−0.14,0.10) | (−0.12,0.11) | (−0.22,0.02) | (−0.20,0.04) | (−0.16,0.08) | (−0.55,0.15) | |
| 11–13 year Physical Activity | ||||||||
| Counts/day × 103 | −0.01* | −0.02** | −0.01* | −0.01* | 0.00 | 0.00 | 0.00 | −0.01 |
| (−0.02,0.00) | (−0.03,−0.01) | (−0.02,0.00) | (−0.02,0.00) | (−0.01,0.01) | (−0.01,0.01) | (−0.01,0.00) | (−0.03,0.02) | |
| % time Moderate | −0.04 | −1.17** | −0.04 | −0.05* | −0.01 | −0.01 | −0.01 | −0.03 |
| (−0.08,0.10) | (−1.49,−0.85) | (−0.09,0.00) | (−0.09,0.00) | (−0.06,0.03) | (−0.05,0.04) | (−0.05,0.04) | (−0.17,0.10) | |
| % time Vigorous | −0.14* | −2.74** | −0.16* | −0.15* | −0.13* | −0.12* | 0.10 | −0.32 |
| (−0.26,−0.02) | (−3.61,−1.86) | (−0.28,−0.04) | (−0.26,−0.03) | (−0.25,−0.01) | (−0.24,−0.01) | (−0.02,0.22) | (−0.68,0.04) | |
§Eisenmann et al. [26] *p < 0.05, **p < 0.001. HOMA-IR Homeostasis Model Assessment for insulin resistance, SBP systolic blood pressure, B Beta, CI confidence interval
Multivariate linear regression models with physical activity measures as independent variables and 13.5 year cardiometabolic risk factors as the dependent variables (n = 290)†
| 13.5y Risk Factors | ||||||||
|---|---|---|---|---|---|---|---|---|
| HOMA-IR | Fat % | Sum of Skinfolds (mm) | Waist Circumference (cm) | Total:HDL Cholesterol | Triglycerides | SBP (mmHg) | Metabolic Syndrome Score§ | |
| B (95% CI) | ||||||||
| 6–10 year Physical Activity | ||||||||
| Counts/day × 103 | −0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.01 | −0.01 |
| (−0.02, 0.00) | (−0.01,0.01) | (− 0.01,0.01) | (− 0.01,0.01) | (− 0.01,0.01) | (− 0.01,0.01) | (− 0.02,0.00) | (− 0.01,0.02) | |
| % time Moderate | − 0.05 | − 0.08 | 0.02 | 0.01 | 0.01 | 0.01 | − 0.02 | 0.05 |
| (− 0.12, 0.02) | (− 0.31,0.46) | (−0.04,0.08) | (− 0.05,0.06) | (− 0.06,0.06) | (− 0.06,0.07) | (− 0.08,0.04) | (− 0.23,0.13) | |
| % time Vigorous | − 0.08 | −0.11 | − 0.05 | − 0.05 | −0.12 | −0.10 | − 0.08) | − 0.40* |
| (− 0.22, 0.05) | (− 0.87,-0.66) | (− 0.17,0.06) | (− 0.16,0.06) | (− 0.24,0.02) | (− 0.23,0.03) | (− 0.20,0.04) | (− 0.75,0.05) | |
| 11–13 year Physical Activity | ||||||||
| Counts/day × 103 | −0.01* | −0.01* | −0.01 | − 0.01 | 0.00 | 0.00 | 0.00 | −0.02 |
| (−0.02,0.00) | (−0.01,−0.00) | (−0.02,0.00) | (− 0.02,0.00) | (− 0.01,0.01) | (− 0.01,0.01) | (−0.01,0.01) | (− 0.01,0.01) | |
| % time Moderate | −0.04 | −0.44* | −0.04 | − 0.05* | −0.04 | −0.02 | 0.01 | −0.15* |
| (−0.10,0.14) | (−0.77,−0.11) | (−0.09,0.01) | (− 0.10,0.00) | (− 0.09,0.02) | (− 0.08,0.03) | (−0.05,0.06) | (− 0.30,0.00) | |
| % time Vigorous | −0.20* | −0.06* | −0.19* | − 0.17* | −0.15* | −0.13 | 0.20 | −0.51* |
| (−0.36,−0.03) | (−0.11,−0.01) | (−0.33,−0.05) | (− 0.30,−0.03) | (− 0.31,−0.00) | (− 0.29,−0.02) | (0.00,0.35) | (− 0.94,-0.08) | |
†Models adjusted for Age at activity assessment, sex, pubertal stage at 13.5 years, standard of living, maternal GDM status. §Eisenmann et al. [26] *p < 0.05. HOMA-IR Homeostasis Model Assessment for insulin resistance SBP systolic blood pressure, B Beta, CI confidence interval